🟢 Noveris Health Sciences is trading 7.14% up today as biotech ETF XBI rises 2.55%

Noveris Health Sciences is trading at CA$0.07, up +7.14%, primarily as the biotechnology sector rallies.

• No new company-specific announcement was identified for September 17, 2026; the latest reported item was the September 4 annual meeting, announced September 9.
• Biotech ETF XBI rose 2.55% during regular trading; major U.S. indices also rose, supporting broader risk appetite.
• The gain follows a 17.65% decline on September 16, suggesting rebound activity rather than a confirmed corporate catalyst.